What is the mechanism of amnioinfusion?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 15, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Mechanism of Amnioinfusion

Amnioinfusion works by infusing normal saline solution into the uterine cavity to increase amniotic fluid volume, which relieves umbilical cord compression and dilutes meconium when present. 1

Primary Mechanisms of Action

  • Amnioinfusion relieves umbilical cord compression by increasing the amniotic fluid volume, thereby creating more space around the umbilical cord and reducing the risk of compression during contractions 1, 2
  • It dilutes meconium when present in the amniotic fluid, potentially reducing the risk of meconium aspiration syndrome 3, 4
  • It improves the intrauterine environment by correcting oligohydramnios, which is often associated with variable decelerations in fetal heart rate 5, 4

Clinical Applications

During Labor

  • Amnioinfusion is indicated for recurrent, moderate to severe variable decelerations in fetal heart rate during labor 1
  • The procedure involves infusing room temperature normal saline (0.9%) through an intrauterine pressure catheter 5
  • Typically performed as either:
    • A bolus infusion followed by continuous slow infusion, or
    • Repeated bolus infusions to maintain adequate amniotic fluid volume 6

For Meconium-Stained Amniotic Fluid

  • Amnioinfusion dilutes thick meconium, potentially reducing the risk of meconium aspiration syndrome 3
  • Under standard perinatal surveillance, amnioinfusion has been shown to reduce:
    • Heavy meconium staining of amniotic fluid
    • Variable fetal heart rate decelerations
    • Cesarean section rates 3

For Previable PPROM (Preterm Prelabor Rupture of Membranes)

  • Serial amnioinfusions have been investigated for previable PPROM (16-24 weeks)
  • However, randomized trials found no significant reduction in perinatal morbidity compared to expectant management 1
  • Current guidelines consider serial amnioinfusions for previable PPROM investigational and recommend they be used only in clinical trial settings 1

Procedural Considerations

  • For intrapartum use, normal saline is typically infused through an intrauterine catheter, preferably one with a catheter-tip pressure transducer 6
  • The goal is to achieve and maintain adequate amniotic fluid volume throughout labor 6
  • Monitoring is essential to prevent complications such as uterine overdistention 5

Efficacy and Outcomes

  • In cases of variable decelerations during labor, amnioinfusion has been associated with:
    • Reduced variable fetal heart rate decelerations
    • Lower cesarean delivery rates
    • Improved umbilical artery and venous blood gas values 5, 4
  • For meconium-stained fluid, benefits include:
    • Reduced meconium below the vocal cords
    • Decreased incidence of meconium aspiration syndrome
    • Reduced need for neonatal ventilation 6

Potential Complications

  • Umbilical cord prolapse
  • Uterine overdistention
  • Fetal bradycardia
  • Rare reports of amniotic fluid embolism 5

Amnioinfusion represents an important tool in modern obstetric practice, particularly for managing variable decelerations and meconium-stained amniotic fluid during labor, though its use for previable PPROM remains investigational.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Amnioinfusion: a technique for the relief of variable deceleration.

Journal of obstetric, gynecologic, and neonatal nursing : JOGNN, 1990

Research

Amnioinfusion for meconium-stained liquor in labour.

The Cochrane database of systematic reviews, 2002

Research

What is the role of amnioinfusion in modern day obstetrics?

The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians, 2016

Research

Amnioinfusion: a review.

Obstetrical & gynecological survey, 1993

Research

Amnioinfusion.

European journal of obstetrics, gynecology, and reproductive biology, 1996

Related Questions

What is the management plan for a 34-year-old woman, gravida 5 para 4, at 39 weeks gestation with a history of uncomplicated pregnancy, prepregnancy body mass index (BMI) of 33 kg/m2, and a weight gain of 18 kg, who presents with contractions and spontaneous rupture of membranes, and develops recurrent variable decelerations after receiving neuraxial anesthesia, which resolve with amnioinfusion?
What is the ideal amnioinfusion (intra-amniotic infusion) bolus volume?
What is the interpretation of fetal heart tracings (FHTs) showing Category II with repetitive late decelerations, moderate variability, and accelerations, indicating an overall reactive and reassuring pattern?
What are the risks of accidental D5LR (5% Dextrose in Lactated Ringer's solution) intrauterine infusion during amnioinfusion?
What is the next step in managing a patient with renal lesions, including a 13mm peripherally calcified lesion, hyperdense renal cortical lesions, and bilateral renal cortical hypodensities, along with other findings such as degenerative changes in the spine and hip joints, and vascular calcification?
At what creatinine (creatinuria) to proteinuria ratio can nephrotic syndrome be estimated?
What is the management approach for a patient with elevated anti-thyroid peroxidase (anti-TPO) antibodies but normal Thyroid-Stimulating Hormone (TSH) levels?
What is the treatment for reactive lymphocytes?
What is the management of opsoclonus-myoclonus syndrome (OMS) suspected to be related to tramadol (generic name: tramadol) use in pediatric patients?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.